XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.

XM은(는) 미국 국적의 시민에게 서비스를 제공하지 않습니다.
C
C

Cigna

뉴스

Reuters - 1 주 전

CVS, UnitedHealth, Cigna ask FTC's Khan to disqualify herself from insulin case

UPDATE 1-CVS, UnitedHealth, Cigna ask FTC's Khan to disqualify herself from insulin case Adds Cigna statement in paragraphs 1, 2 and 6 By Amina Niasse NEW YORK, Oct 9 (Reuters) - CVS Health CVS.N , UnitedHealth Group UNH.N and Cigna CI.N have asked U.S. Federal Trade Commission chair Lina Khan and commissioners Rebecca Kelly Slaughter and Alvaro Bedoya to disqualify themselves from an FTC lawsuit that has accused the companies of unlawfully inflating insulin prices.
A
C
Reuters - 2 주 전

CVS Health rises as TD Cowen upgrades to "buy" on Medicare optimism

BUZZ-CVS Health rises as TD Cowen upgrades to "buy" on Medicare optimism ** Shares of CVS Health Corp CVS.N rise 3.1% to a near five-month high of $64.87 ** Brokerage TD Cowen upgrades stock to "buy" from "hold" and hikes PT to $85 from $59 - which represents a 35% upside to stock's last close ** Brokerage says it is confident in CVS achieving doub
C
Reuters - 2 주 전

Texas attorney general sues insulin makers and pharmacy middlemen over high costs

UPDATE 1-Texas attorney general sues insulin makers and pharmacy middlemen over high costs Adds OptumRx, Cigna and Sanofi responses in paragraphs 11-15 Oct 3 (Reuters) - The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of collaborating to inflate the cost of insulin. Texas Attorney General Ken Paxton's office said on Thursday it had sued insulin makers Eli Lilly LLY.N , Novo Nordisk NOVOb.CO and Sanofi SASY.PA .
C
S
Reuters - 2 주 전

Texas attorney general sues insulin makers and pharmacy middlemen over high costs

Texas attorney general sues insulin makers and pharmacy middlemen over high costs Oct 3 (Reuters) - The Texas attorney general has sued leading insulin manufacturers and pharmacy benefit managers (PBMs), accusing them of collaborating to inflate the cost of insulin. Texas Attorney General Ken Paxton's office said on Thursday it had sued insulin makers Eli Lilly LLY.N , Novo Nordisk NOVOb.CO and Sanofi SASY.PA .
C
S
Reuters - 2 주 전

Texas Attorney General Ken Paxton Sues Pharma Drug Manufacturers & Pharmacy Benefit Managers For "Conspiracy" That Increased Insulin Prices By 1,000%

BRIEF-Texas Attorney General Ken Paxton Sues Pharma Drug Manufacturers & Pharmacy Benefit Managers For "Conspiracy" That Increased Insulin Prices By 1,000% Oct 3 (Reuters) - Texas Attorney General Ken Paxton: TEXAS ATTORNEY GENERAL KEN PAXTON: SUES PHARMA DRUG MANUFACTURERS & PHARMACY BENEFIT MANAGERS FOR "CONSPIRACY" THAT INCREASED INSULIN PRICES
C
Reuters - 2 주 전

Humana slips as members in Medicare Advantage plans fall for 2025

BUZZ-Humana slips as members in Medicare Advantage plans fall for 2025 Updates ** Shares of health insurer Humana HUM.N fall as much as 23.7% to an over 4-year low of $213.31 ** Company says total members enrolled in its highly rated Medicare Advantage (MA) plans for people aged 65 years and above have reduced for 2025 ** HUM has about 1.6 mln, or 25%, of its members currently enrolled in plans rated 4 stars and above for 2025, down from 94% in 2024 ** Brokerage Evercore ISI says the news is pos
C
Reuters - 2 주 전

CVS surgery would provide little if any relief

RPT-BREAKINGVIEWS-CVS surgery would provide little if any relief The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Robert Cyran NEW YORK, Oct 1 (Reuters Breakingviews) - It’s easier to diagnose what ails CVS Health CVS.N than it is to prescribe a cure. Multiple profit warnings from the $78 billion healthcare conglomerate have raised doubts about its strategy.
A
C
W
Reuters - 2 주 전

CVS surgery would provide little if any relief

RPT-BREAKINGVIEWS-CVS surgery would provide little if any relief The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Robert Cyran NEW YORK, Oct 1 (Reuters Breakingviews) - It’s easier to diagnose what ails CVS Health CVS.N than it is to prescribe a cure. Multiple profit warnings from the $78 billion healthcare conglomerate have raised doubts about its strategy.
A
C
W
Reuters - 2 주 전

CVS surgery would provide little if any relief

BREAKINGVIEWS-CVS surgery would provide little if any relief The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Robert Cyran NEW YORK, Oct 1 (Reuters Breakingviews) - It’s easier to diagnose what ails CVS Health CVS.N than it is to prescribe a cure. Multiple profit warnings from the $78 billion healthcare conglomerate have raised doubts about its strategy.
A
C
W
Reuters - 2 주 전

CVS explores options including potential break-up, sources say

RPT-EXCLUSIVE-CVS explores options including potential break-up, sources say Adds background and details on CVS from paragraph 11 onwards By Anirban Sen NEW YORK, Sept 30 (Reuters) - CVS Health CVS.N is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.
C
Reuters - 2 주 전

Health insurers unveil Medicare Advantage plans for 2025

UPDATE 2-Health insurers unveil Medicare Advantage plans for 2025 Adds details on UnitedHealth's plans in paragraphs 10 and 11 Oct 1 (Reuters) - Health insurers Cigna CI.N , CVS Health CVS.N , Humana HUM.N Centene CNC.N and UnitedHealth UNH.N on Tuesday released details on their government-backed health insurance plans for next year for people aged 65 and above.
C
Reuters - 2 주 전

CVS, Cigna unveil Medicare Advantage plans for 2025

CVS, Cigna unveil Medicare Advantage plans for 2025 Oct 1 (Reuters) - CVS Health CVS.N and Cigna CI.N on Tuesday released details on their government-backed health insurance plans for next year for people aged 65 and above , saying some members would pay $0 premium monthly for prescription drugs. The announcements come ahead of the beginning of enrollment for Medicare Advantage plans on October 15, which will continue through December 7. Medicare Advantage plans are offered by private insurers w
C
Reuters - 3 주 전

CVS explores options including potential break-up, sources say

EXCLUSIVE-CVS explores options including potential break-up, sources say Adds background and details on CVS from paragraph 11 onwards By Anirban Sen NEW YORK, Sept 30 (Reuters) - CVS Health CVS.N is exploring options that could include a break-up of the company to separate its retail and insurance units, as the struggling healthcare services company looks to turn around its fortunes amid pressure from investors, people familiar with the matter told Reuters.
C
Reuters - 3 주 전

US Senator Sanders says middlemen won't punish Novo if it cuts weight-loss drug prices

UPDATE 4-US Senator Sanders says middlemen won't punish Novo if it cuts weight-loss drug prices Adds Lilly background in paragraph 7, CEO comment on working with PBMs, paragraph 11 By Ahmed Aboulenein and Patrick Wingrove WASHINGTON, Sept 24 (Reuters) - U.S. Senator Bernie Sanders said on Tuesday he had commitments from the nation's top pharmacy benefit managers that they would expand coverage of Novo Nordisk's NOVOb.CO popular diabetes and weight-loss medicines if the company lowered the list p
C
Reuters - 4 주 전

What to Watch in the Day Ahead - Tuesday, September 24

What to Watch in the Day Ahead - Tuesday, September 24 The Day Ahead is an email and PDF publication that includes the day's major stories and events, analyses and other features. To receive The Day Ahead, Eikon users can register at DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT Federal Reserve Board Governor Michelle Bowman is slated to speak on the economic outlook and monetary policy before the Kentucky Bankers Association Annual Convention in Virginia.
C
Reuters - 4 주 전

Why are US pharmacy benefit managers under fire?

EXPLAINER-Why are US pharmacy benefit managers under fire? By Ahmed Aboulenein WASHINGTON, Sept 20 (Reuters) - The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to artificially inflate the cost of insulin.
C
Reuters - 4 주 전

US FTC sues drug 'gatekeepers' over high insulin prices

UPDATE 3-US FTC sues drug 'gatekeepers' over high insulin prices Adds outside comment in paragraphs 6-7, drug company comment in paragraph 18, investor comment in paragraphs 21-22 By Jody Godoy and Ahmed Aboulenein Sept 20 (Reuters) - The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetes patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
C
S
Reuters - 4 주 전

US FTC sues drug 'gatekeepers' over high insulin prices

US FTC sues drug 'gatekeepers' over high insulin prices By Jody Godoy and Ahmed Aboulenein Sept 20 (Reuters) - The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of steering diabetic patients towards higher priced insulin in order to reap millions of dollars in rebates from pharmaceutical companies.
C
S
Reuters - 4 주 전

U.S. STOCKS AppLovin, Regal Rexnord, Talkspace

BUZZ-U.S. STOCKS ON THE MOVE- AppLovin, Regal Rexnord, Talkspace Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main stock indexes rose on Tuesday, with the S&P 500 hitting an intraday record high ahead of a crucial Federal Reserve interest-rate decision, after fresh economic data allayed worries of a sharp slowdown in the U.S.
A
C
I
M
N
S
U
U
D
Reuters - 4 주 전

Express Scripts sues FTC over drug pricing report, court documents show

UPDATE 2-Express Scripts sues FTC over drug pricing report Adds detail from the complaint and FTC comment in paragraphs 4-8, updates headline, byline and dateline By Jody Godoy NEW YORK, Sept 17 (Reuters) - Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report , calling the report's conclusion that the prescription middlemen raise drug costs defamatory.
C

조건

인기 자산

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.